ACI’s Drug and Medical Device Litigation Conference has united leaders in the pharmaceutical and medical device product liability defense bar for the last quarter century. Designed for master’s-level strategy-sharing and bringing together hundreds of industry leaders from in-house, private practice, and government, this is the forum at which to gain essential life sciences product liability litigation strategies.
On December 6, Julie Park will moderate a session entitled “Maximizing the Chances of Success in a ‘Bet-the-Company’ Product Liability Litigation” at 5:00 p.m. ET. The session will touch on best practices for utilizing a mock trial, processes and criteria for selecting expert witnesses, tools for success in direct examinations and cross-examinations, and partnering with in-house counsel to make critical strategic decisions.
On December 7, Jessica Grant will speak at the “Examining Risks and Liabilities Associated with New Cutting Edge MedTech and HealthTech” session at 1:00 p.m. ET. This session will analyze the latest advancements in MedTech and HealthTech that are disrupting the industry.
The conference is scheduled for December 6–7, 2021 at the New York Marriott Marquis. Register for this conference.